Cargando…
TAK1 inhibition improves myoblast differentiation and alleviates fibrosis in a mouse model of Duchenne muscular dystrophy
BACKGROUND: Transforming growth factor‐β‐activated kinase 1 (TAK1) plays a key role in regulating fibroblast and myoblast proliferation and differentiation. However, the TAK1 changes associated with Duchenne muscular dystrophy (DMD) are poorly understood, and it remains unclear how TAK1 regulation c...
Autores principales: | Xu, Dengqiu, Li, Sijia, Wang, Lu, Jiang, Jingwei, Zhao, Lei, Huang, Xiaofei, Sun, Zeren, Li, Chunjie, Sun, Lixin, Li, Xihua, Jiang, Zhenzhou, Zhang, Luyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890152/ https://www.ncbi.nlm.nih.gov/pubmed/33236534 http://dx.doi.org/10.1002/jcsm.12650 |
Ejemplares similares
-
A potential therapeutic effect of catalpol in Duchenne muscular dystrophy revealed by binding with TAK1
por: Xu, Dengqiu, et al.
Publicado: (2020) -
Circulating Muscle-specific miRNAs in Duchenne Muscular Dystrophy Patients
por: Li, Xihua, et al.
Publicado: (2014) -
Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012) -
Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021) -
Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update
por: Sun, Chengmei, et al.
Publicado: (2020)